Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea (Q44216643)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea |
scientific article published in November 2002 |
Statements
1 reference
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea (English)
1 reference
1 reference
1 reference
Frances A Shepherd
1 reference
Lesley Seymour
1 reference
Channa Debruyne
1 reference
Andrea Bezjak
1 reference
Vera Hirsh
1 reference
Michael Smylie
1 reference
Sheldon Rubin
1 reference
Heidi Martins
1 reference
Alan Lamont
1 reference
Anna Sadura
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference